28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Marcus Hannakam: We think consolidation will proceed...
28.09.2017
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...
28.09.2017
- Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...
27.09.2017
- In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...
27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
27.04.2017
- Chinese outbound foreign investment continues to beat records year by year. The Asian powerhouse is investing in overseas markets to acquire advanced technology, know-how and...
26.04.2017
- After robust yet modest chemicals M&A activity in 2016, expectations for the year ahead are high. The value of completed deals in 2016 decreased slightly against 2015 to around...
